No Data
No Data
Chengyitong (300430.SZ): The core product automated biological fermentation control system has many applications in the field of synthetic biology
Gelonghui, May 9, 丨 Chengyitong (300430.SZ) held a performance briefing on May 8, 2024 to discuss “Are there synthetic biological-related technologies currently being developed by the company?” The company replied that downstream customers in the company's intelligent manufacturing sector mainly include pharmaceutical and biological manufacturing companies. Biomaneling is mainly a production method using synthetic biotechnology as an important technical support and biological fermentation process as an important means of implementation. The company's core product, the automated biological fermentation control system, has many applications in the field of synthetic biology. Driven by synthetic biotechnology and green biological manufacturing, 202
Chengyitong (300430.SZ): Currently, the company is focusing on the market-based implementation of non-intrusive brain-computer interface technology and the R&D and development of invasive technology
Gelonghui, May 9, 丨 Chengyitong (300430.SZ) held a performance briefing on May 8, 2024 to discuss “Can the brain-computer products the company is developing regenerate insulin to treat diabetes?” The company replied that currently, the company is focusing on the market-based implementation of non-intrusive brain-computer interface technology and the R&D and development of intrusive technology. In planning non-invasive technology, the company integrates existing rehabilitation products with brain-computer interfaces to achieve product upgrades, thereby providing more effective rehabilitation services for patients with neurological diseases. In the future, the company will also focus on the application of brain-computer interfaces in other medical fields
Chengyitong (300430.SZ) announced first-quarter results, net profit of 307.813 million yuan, an increase of 37.71%
Chengyitong (300430.SZ) released its report for the first quarter of 2024, achieving 2.68 operating income during the reporting period...
Chengyitong (300430.SZ) issued 2023 annual results, with net profit of 170 million yuan, an increase of 36.30% over the previous year
Chengyitong (300430.SZ) released its 2023 annual report. The company achieved operating income of 11 during the reporting period...
Chengyitong (300430.SZ): Long Zhijie has now developed products such as transcranial magnetic navigation systems and magnetic brain stimulation therapy devices
Gelonghui, April 12, 丨 Chengyitong (300430.SZ) said on the investor interactive platform that the company has always attached great importance to technical reserves and product development in brain science. The rehabilitation industry is one of the most successful and extensive fields of application of related technology. Long Zhijie began exploring related technologies in 2020. Currently, it has developed products such as transcranial magnetic navigation systems and magnetic brain stimulation therapy devices, and established Beijing Brain Link Technology Co., Ltd. on March 28, 2024. In the future, it will rely on Brain Connect Technology's platform to further explore brain-computer interface related technology and carry out related technical research and product development work, for big
Chengyitong (300430.SZ): Will rely on BrainLink Technology's platform to explore brain-computer interface-related technologies in depth
Gelonghui, April 8, 丨 Chengyitong (300430.SZ) said on the interactive platform that the company established Beijing Brain Connect Technology Co., Ltd. on March 28, 2024. The company will rely on BrainConnect Technology's platform to thoroughly explore brain-computer interface-related technologies, first using Longzhijie's existing products to achieve non-invasive brain function upgrades, and support R&D teams to explore invasive brain-computer technology research and development. The company will continue to cooperate deeply with senior teams from well-known universities to actively explore the application of brain science in the field of rehabilitation and medicine.
No Data